Vaccination with a Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Cervical Cancer Vaccine in Korean Girls Aged 10-14 Years

The human papillomavirus (HPV)-16/18 AS04-adjuvanted cervical cancer vaccine has been demonstrated to be highly efficacious and immunogenic with a favorable safety profile. This study assessed the immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Korean girls aged 10-14 y...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Young-Jae, Kim, Kyung-Tai, Kim, Jae-Hoon, Cha, Soon-Do, Kim, Jae Weon, Bae, Duk-Soo, Nam, Joo-Hyun, Ahn, Woong-Shick, Choi, Ho-Sun
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908791/
https://www.ncbi.nlm.nih.gov/pubmed/20676333
http://dx.doi.org/10.3346/jkms.2010.25.8.1197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908791/
https://www.ncbi.nlm.nih.gov/pubmed/20676333
http://dx.doi.org/10.3346/jkms.2010.25.8.1197

Ejemplares similares